Please Wait.....
Report
Global Natural Killer (NK) Cell Therapeutics Market: Investment & Growth Opportunity Analysis, 2019-2028
Market Report I 2022-09-01 I 120 Pages I RationalStat
Global Natural Killer (NK) Cell Therapeutics Market: Investment & Growth Opportunity Analysis, 2019-2028
Market Introduction
The Global Natural Killer (NK) Cell Therapeutics market is estimated to grow at a robust CAGR of 51.8% during the forecast period of 2022-2028. The market growth is attributed to the increasing interest of the pharmaceutical industry players in cellular immunotherapy. NK cell therapeutics is anticipated to witness robust growth during the forecast period owing to its ability to fulfil unmet medical needs, overcome limitations associated with existing immunotherapies, and address complex and challenging targets.
The recent increase in the number of approvals received for cancer immunotherapies is considered to have added value to the NK cell therapeutic market. Moreover, market players are making efforts for the development of novel NK cell therapies which further gives a boost to the growth of the market. For instance, Under the agreement, Gilead would receive an exclusive, worldwide license from Dragonfly for the 5T4-targeting investigational immunotherapy program, DF7001. DF7001 is a TriNKET designed to activate and direct NK and cytotoxic T cell killing against cancer cells. The target of DF7001 is 5T4, a protein expressed on cancer cells and stromal cells that support tumor growth associated with poor prognosis in several cancers, including non-small cell lung cancer (NSCLC), pancreatic cancer, breast cancer, and head and neck squamous cell carcinomas (HNSCC).
Market Segmentation
The global NK cell therapeutics market has been analyzed on the basis of application, end user, and region. On the basis of application, the market is segmented into Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others. Cancer segment is expected to dominate the global market. Based on end user, the market is divided into hospitals and research centers & institutes. Geographically, the market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific and Middle East & Africa. North America is dominating the global NK cell therapeutics market.
Market Structure and Competitive Landscape
Some of the prominent players that contribute significantly to the growth of the global NK cell therapeutics market include Nkarta, Inc, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Affimed GmbH, Zelluna Immunotherapy, Nektar Therapeutics, XNK Therapeutics AB, ONK Therapeutics, Catarman Bio, MiNK Therapeutics, Celularity Inc., Artiva Biotherapeutics and others. These players adopt various strategies to reinforce their market share and gain a competitive edge over other competitors in the market. Partnerships and collaborations, research & development, and product launches are some of the strategies followed by industry players. Some of the key developments in the global NK cell therapeutics market include,
- In August 2022, Zelluna Immunotherapy announced an investment from Takeda Ventures, Inc. (TVI), the strategic investing arm of Takeda. TVI investment joins Zelluna's latest financing round. The funds will enable the advancement of a lead TCR-NK product through manufacturing to Clinical Trial Application (CTA) / Investigational New Drug Application (IND) readiness and, continue the advancement of Zelluna's platform with additional programs reaching the preclinical stage.
- In January 2022, Takeda announced to acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (??) T Cell Engager Therapies Targeting Solid Tumors. Through the acquisition, Takeda would obtain Adaptate's antibody-based ?? T cell engager platform, including pre-clinical candidate and discovery pipeline programs.
Global NK Cell Therapeutics Market Analysis and Forecast 2019-2028
Table of Contents
1. Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation
2. Assumptions and Acronyms
3. Executive Summary
3.1. Global Market in 2022
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends
4. Research Methodology
5. Analysis of COVID-19 Impact and Road Ahead
6. Market Indicators and Background
6.1. Macro-Economic Factors
6.2. Forecasting Factors
Robust assessment of various factors including industrial performance, healthcare expenditures, industry players' expenditures, economic conditions, among others
6.3. Supply Chain & Value Chain Analysis
6.4. Industry SWOT Analysis
6.5. PESTLE Analysis
6.6. Porter's Five Forces Analysis
7. Government Laws and Industry Regulations
8. Global and Regional Market Dynamics
8.1. Drivers
8.2. Restraints
8.3. Trends
8.4. Opportunities
9. Global NK Cell Therapeutics Market: Key Investment Analysis
9.1. By Key Industry Players
9.2. By End User
9.3. By Therapeutic Application
9.4. By Region
9.5. M&A Activities
Robust assessment of major investments made by various industry players along with key therapeutic application areas, therapy type, and key region
10. Parent Market Overview: Global Healthcare & Life Sciences Market
11. Market Developments: Cell & Gene Therapy Products
11.1. By Region
11.1.1. North America
11.1.2. Latin America
11.1.3. Western Europe
11.1.4. Eastern Europe
11.1.5. Asia Pacific
11.1.6. Middle East & Africa
12. Clinical Trials Analysis
Exhaustive list of all the clinical trials sponsored by various industry players based on various cell types will be provided. Moreover, it would also categorize the trials into IND submissions, Phase I, Phase II etc.
13. Segmental Analysis
13.1. Global NK Cell Therapeutics Market by Application
13.1.1. Segment Overview
13.1.1.1. Cancer
13.1.1.2. Gastrointestinal Diseases
13.1.1.3. Immunoproliferative Disorders
13.1.1.4. Others
13.2. Global NK Cell Therapeutics Market by End User
13.2.1. Segment Overview
13.2.1.1. Hospitals
13.2.1.2. Research Centers and Institutes
13.2.1.3. Others
13.3. Global NK Cell Therapeutics Market by Region
13.3.1. North America
13.3.2. Latin America
13.3.3. Western Europe
13.3.4. Eastern Europe
13.3.5. Asia Pacific
13.3.6. Middle East & Africa
14. Regional Analysis
14.1. North America NK Cell Therapeutics Market Analysis and Forecast 2019-2028
14.1.1. Regional Market Overview and Key Takeaways
14.1.2. North America NK Cell Therapeutics Market by Application
14.1.3. North America NK Cell Therapeutics Market by End User
14.1.4. North America NK Cell Therapeutics Market by Country
14.1.4.1. US
14.1.4.2. Canada
14.2. Latin America NK Cell Therapeutics Market Analysis and Forecast 2019-2028
14.2.1. Regional Market Overview and Key Takeaways
14.2.2. Latin America NK Cell Therapeutics Market by Application
14.2.3. Latin America NK Cell Therapeutics Market by End User
14.2.4. Latin America NK Cell Therapeutics Market by Country
14.2.4.1. Brazil
14.2.4.2. Mexico
14.2.4.3. Rest of Latin America
14.3. Western Europe NK Cell Therapeutics Market Analysis and Forecast 2019-2028
14.3.1. Regional Market Overview and Key Takeaways
14.3.2. Western Europe NK Cell Therapeutics Market by Application
14.3.3. Western Europe NK Cell Therapeutics Market by End User
14.3.4. Western Europe NK Cell Therapeutics Market by Country
14.3.4.1. Germany
14.3.4.2. UK
14.3.4.3. France
14.3.4.4. Spain
14.3.4.5. Italy
14.3.4.6. Benelux
14.3.4.7. Nordic
14.3.4.8. Rest of Western Europe
14.4. Eastern Europe NK Cell Therapeutics Market Analysis and Forecast 2019-2028
14.4.1. Regional Market Overview and Key Takeaways
14.4.2. Eastern Europe NK Cell Therapeutics Market by Application
14.4.3. Eastern Europe NK Cell Therapeutics Market by End User
14.4.4. Eastern Europe NK Cell Therapeutics Market by Country
14.4.4.1. Russia
14.4.4.2. Poland
14.4.4.3. Rest of Eastern Europe
14.5. Asia Pacific NK Cell Therapeutics Market Analysis and Forecast 2019-2028
14.5.1. Regional Market Overview and Key Takeaways
14.5.2. Asia Pacific NK Cell Therapeutics Market by Application
14.5.3. Asia Pacific NK Cell Therapeutics Market by End User
14.5.4. Asia Pacific NK Cell Therapeutics Market by Country
14.5.4.1. China
14.5.4.2. Japan
14.5.4.3. India
14.5.4.4. South Korea
14.5.4.5. Australia
14.5.4.6. ASEAN
14.5.4.7. Rest of Asia-Pacific
14.6. Middle East & Africa NK Cell Therapeutics Market Analysis and Forecast 2019-2028
14.6.1. Regional Market Overview and Key Takeaways
14.6.2. Middle East & Africa NK Cell Therapeutics Market by Application
14.6.3. Middle East & Africa NK Cell Therapeutics Market by End User
14.6.4. Middle East & Africa NK Cell Therapeutics Market by Country
14.6.4.1. GCC
14.6.4.2. South Africa
14.6.4.3. Turkey
14.6.4.4. Rest of the Middle East & Africa
15. Competitive Landscape
15.1. Competition Dashboard
15.1.1. Global and Regional Market Share Analysis
15.1.2. Market Structure
15.2. Competitive Benchmarking
15.3. Key Strategy Analysis
15.4. Company Profiles
15.4.1. Affimed GmbH
15.4.1.1. Company Overview
15.4.1.2. Application/Service Offerings
15.4.1.3. Key Financials
15.4.1.4. Recent Developments
15.4.2. Bristol-Myers Squibb Company
15.4.2.1. Company Overview
15.4.2.2. Application/Service Offerings
15.4.2.3. Financials
15.4.2.4. Recent Developments
15.4.3. Nkarta Inc.
15.4.3.1. Company Overview
15.4.3.2. Application/Service Offerings
15.4.3.3. Financials
15.4.3.4. Recent Developments
15.4.4. Zelluna Immunotherapy AS
15.4.4.1. Company Overview
15.4.4.2. Application/Service Offerings
15.4.4.3. Financials
15.4.4.4. Recent Developments
15.4.5. XNK Therapeutics AB
15.4.5.1. Company Overview
15.4.5.2. Application/Service Offerings
15.4.5.3. Financials
15.4.5.4. Recent Developments
15.4.6. ONK Therapeutics
15.4.6.1. Company Overview
15.4.6.2. Application/Service Offerings
15.4.6.3. Financials
15.4.6.4. Recent Developments
15.4.7. Catamaran Bio
15.4.7.1. Company Overview
15.4.7.2. Application/Service Offerings
15.4.7.3. Financials
15.4.7.4. Recent Developments
15.4.8. MiNK Therapeutics
15.4.8.1. Company Overview
15.4.8.2. Application/Service Offerings
15.4.8.3. Financials
15.4.8.4. Recent Developments
15.4.9. Takeda Pharmaceutical Company Limited
15.4.9.1. Company Overview
15.4.9.2. Application/Service Offerings
15.4.9.3. Financials
15.4.9.4. Recent Developments
15.4.10. Celularity Inc.
15.4.10.1. Company Overview
15.4.10.2. Application/Service Offerings
15.4.10.3. Financials
15.4.10.4. Recent Developments
15.4.11. Artiva Biotherapeutics
15.4.11.1. Company Overview
15.4.11.2. Application/Service Offerings
15.4.11.3. Financials
15.4.11.4. Recent Developments
A comprehensive list of NK cell therapeutics providers will be provided along with geographical reach, employee count, revenue, product capacities, and their capabilities
16. Disclaimer
Global Natural Killer (NK) Cell Therapeutics Market
List of Figures
Figure 01: Global Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones), 2019-2021
Figure 02: Global Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) & Y-o-Y Growth (%) Analysis, 2022-2028
Figure 03: Natural Killer (NK) Cell Therapeutics, Pricing Analysis per unit (US$), in 2022
Figure 04: Natural Killer (NK) Cell Therapeutics, Pricing Forecast per unit (US$), in 2028
Figure 05: Global Natural Killer (NK) Cell Therapeutics Market Value Analysis (US$ Mn), 2019-2021
Figure 06: Global Natural Killer (NK) Cell Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2028
Figure 07: Global Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 08: Global Natural Killer (NK) Cell Therapeutics Market Y-o-Y Analysis (%) by Application, 2022-2028
Figure 09: Global Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by End User, 2022 & 2028
Figure 10: Global Natural Killer (NK) Cell Therapeutics Market Y-o-Y Analysis (%) by End User, 2022-2028
Figure 11: Global Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Region, 2022 & 2028
Figure 12: Global Natural Killer (NK) Cell Therapeutics Market Y-o-Y Growth (%) by Region, 2022-2028
Figure 13: North America Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 14: North America Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by End User, 2022 & 2028
Figure 15: North America Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 16: Latin America Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 17: Latin America Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by End User, 2022 & 2028
Figure 18: Latin America Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 19: Western Europe Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 20: Western Europe Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by End User, 2022 & 2028
Figure 21: Western Europe Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 22: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 23: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by End User, 2022 & 2028
Figure 24: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 25: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 26: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by End User, 2022 & 2028
Figure 27: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 28: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 29: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by End User, 2022 & 2028
Figure 30: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Country, 2022 & 2028
List of Tables
Table 1: Global Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 2: Global Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by Application
Table 3: Global Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 4: Global Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by End User
Table 5: Global Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Region
Table 6: Global Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by Region
Table 7: North America Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 8: North America Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by Application
Table 9: North America Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 10: North America Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by End User
Table 11: North America Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 12: North America Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by Country
Table 13: Latin America Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 14: Latin America Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by Application
Table 15: Latin America Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 16: Latin America Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by End User
Table 17: Latin America Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 18: Latin America Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by Country
Table 19: Western Europe Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 20: Western Europe Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by Application
Table 21: Western Europe Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 22: Western Europe Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by End User
Table 23: Western Europe Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 24: Western Europe Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by Country
Table 25: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 26: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by Application
Table 27: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 28: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by End User
Table 29: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 30: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by Country
Table 31: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 32: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by Application
Table 33: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 34: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by End User
Table 35: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 36: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by Country
Table 37: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 38: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by Application
Table 39: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 40: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by End User
Table 41: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 42: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Volume ('000 tones) Analysis and Forecast 2019-2028, by Country
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security